Business
What’s going on with the Mesoblast (ASX:MSB) share price in 2020?
The Mesoblast limited (ASX: MSB) share price has had an incredibly eventful year.
The stem cell-focused biotech company’s shares have been as high as $5.70 and as low as $1.02.
Today, the Mesoblast share price sits at $2.40 after crashing over 40% lower last week.
What is happening with the Mesoblast share price?
Mesoblast has been extremely busy this year with a number of key trials and applications.
This includes running a trial for remestemcel-L in the treatment of COVID-19 Acute Respiratory Distress Syndrome (ARDS), an application for remestemcel-L to treat paediatric patients with steroid-refractory acute graft versus host disease (SR-aGvHD), and a trial of rexlemestrocel-L in patients with advanced chronic heart…
-
General11 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
General24 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
General16 hours agoTeam Australia wins back-to-back Motocross of Nations titles
-
Business23 hours agoWhy this speculative ASX stock is jumping 6% today